Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Affiliations

• ¹ Department of Electrical Engineering (ESAT) and iMinds Future Health Department, University of Leuven, Kasteelpark Arenberg 10, B-3001, Leuven, Belgium.
• ² Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, N-0310, Oslo, Norway.
• ³ The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
• ⁴ Department of Human Genetics, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium.
• ⁵ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
• ⁶ Big Data Institute, University of Oxford, Old Road, Oxford, OX3 7LF, UK.
• ⁷ Institute for Genomics and Systems Biology, University of Chicago, 900 East 57th Street, Chicago, IL, 60637, USA.
• ⁸ Committee on Genetics, Genomics, and Systems Biology, University of Chicago, 920 East 58th Street, Chicago, IL, 60637, USA.
• ⁹ Department of Pathology, Oslo University Hospital Radiumhospitalet, N-0310, Oslo, Norway.
• ¹⁰ Department of Informatics and Centre for Cancer Biomedicine, University of Oslo, N-0424, Oslo, Norway.
• ¹¹ Department of Ecology and Evolution, University of Chicago, 1101 East 57th Street, Chicago, IL, 60637, USA.
• ¹² Department of Human Genetics, University of Chicago, 920 East 58th Street, Chicago, IL, 60637, USA.
• ¹³ Tempus Labs, Inc., Chicago, IL, USA.
• ¹⁴ The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. [email protected].
• ¹⁵ Department of Human Genetics, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium. [email protected].